On average, participants treated with levacetylleucine for 12 weeks had better fSARA scores compared to when they received a placebo. The FDA has recently approved levacetylleucine (Aqneursa; IntraBio ...

In a recent study, infants of mothers with an influenza infection during pregnancy were significantly more likely to experience febrile seizures, but not epilepsy. The risk of childhood seizures is ...

The needle-free option to treat type 1 allergic reactions, including anaphylaxis, was approved for adults and children who weigh 66 lbs or more on August 9, 2024. Epinephrine nasal spray (neffy; ARS ...

In her September 2024 article, Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, highlights the potential of digital health tools to improve care for pediatric mental health, obesity, and ...

With this approval, FluMist becomes the first vaccine to prevent influenza that does not need to be administered by a health care provider. Influenza Vaccine Live (FluMist; AstraZeneca) is now FDA ...

With this acceptance, the federal agency has assigned a PDUFA date of May 22, 2025 for roflumilast foam (Zoryve) 0.3%. Results from the phase 3 ARRECTOR trial, a phase 2b study, and long-term efficacy ...

Andrew Dauber, MD, MMSc, of Children's National Hospital joined us to discuss potential advantages of LUM-201 as it goes through the clinical pipeline. In this Contemporary Pediatrics interview, ...

In her September 2024 article, Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, highlights the potential of digital health tools to improve care for pediatric mental health, obesity, and ...

Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Andrew Dauber, MD, MMSc, of Children's National Hospital joined us to discuss potential advantages of LUM-201 as it goes through the clinical pipeline.

IIV3s, RIV3, and LAIV3 influenza vaccines are expected to be available.